Literature DB >> 20602033

Peritumoral brain edema in intracranial meningiomas.

Nelson de Azambuja Pereira-Filho1, Fabiano Pasqualotto Soares, Ivan de Mello Chemale, Ligia Maria Barbosa Coutinho.   

Abstract

Occurrence of peritumoral brain edema (PBE) in meningiomas has been associated with several factors in recent years, although its pathophysiological mechanism has not yet been fully elucidated. The aim of this study was to analyze the correlation between the presence / degree of PBE and factors such as gender, age, size and histological subtype of tumor. We analyzed the MRI images of 74 patients operated on Hospital Beneficência Portuguesa de Porto Alegre for the presence / degree of PBE and data was statistically correlated with the parameters of the patient. PBE was present in 70.1% of patients. Tumors with higher volume had more PBE. Tumors of the olfactory groove showed more PBE than sphenoid wing and parassagittal tumors. Transitional subtype showed more PBE than fibroblastic and meningothelial subtypes.

Entities:  

Mesh:

Year:  2010        PMID: 20602033     DOI: 10.1590/s0004-282x2010000300003

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  3 in total

1.  BAG-1 expression in human meningioma and correlation with clinical characteristics.

Authors:  Kaiyu Zhou; Hanghuang Jin; Ting Zhou; Yongkang Luo
Journal:  Med Oncol       Date:  2013-01-16       Impact factor: 3.064

2.  Differentiation between brain glioblastoma multiforme and solitary metastasis: qualitative and quantitative analysis based on routine MR imaging.

Authors:  X Z Chen; X M Yin; L Ai; Q Chen; S W Li; J P Dai
Journal:  AJNR Am J Neuroradiol       Date:  2012-06-28       Impact factor: 3.825

3.  Evaluation of AQP4/TRPV4 Channel Co-expression, Microvessel Density, and its Association with Peritumoral Brain Edema in Intracranial Meningiomas.

Authors:  Konstantinos Faropoulos; Afroditi Polia; Chrisi Tsakona; Eleanna Pitaraki; Athanasia Moutafidi; George Gatzounis; Martha Assimakopoulou
Journal:  J Mol Neurosci       Date:  2021-02-04       Impact factor: 3.444

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.